October 01, 2015
Article
Aziz Nazha, Hematology and Medical Oncology Fellow, Cleveland Clinic, discusses adverse events associated with treatment for myelodysplastic syndrome (MDS).
Aziz Nazha, Hematology and Medical Oncology Fellow, Cleveland Clinic, discusses the future of treating patients with myelodysplastic syndrome (MDS).
Thanking My Support System From My Cancer Journey
Ibtrozi May Address Unmet Needs In ROS1-Positive Non-Small Cell Lung Cancer
Actively Recruiting Trials for Lung, Biliary, AML and Small Cell Cancer
The Lessons of the Woods